Abuduwaili Zulalai, Fan Yingao, Tao Wenyuan, Chen Yanting, Xu Yun, Zhu Xiaolei
Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China.
State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China.
Curr Neuropharmacol. 2025;23(6):635-649. doi: 10.2174/011570159X337659241014140824.
Alzheimer's disease (AD) is the most common neurodegenerative disease leading to dementia in the elderly, and the mechanisms of AD have not been fully defined. Circular RNAs (circRNAs), covalently closed RNAs produced by reverse splicing, have critical effects in the pathogenesis of AD. CircRNAs participate in production and clearance of Aβ and tau, regulate neuroinflammation, synaptic plasticity and the process of apoptosis and autophagy, indicating that circRNAs may be alternative biomarkers and therapeutic targets. Our review summarizes the functions of circRNAs in the progression and development of AD, which provide insights into the prospect of circRNAs in the diagnosis and treatment of AD.
阿尔茨海默病(AD)是导致老年人痴呆的最常见神经退行性疾病,其发病机制尚未完全明确。环状RNA(circRNAs)是通过反向剪接产生的共价闭合RNA,在AD发病机制中具有关键作用。CircRNAs参与β淀粉样蛋白(Aβ)和tau蛋白的产生与清除,调节神经炎症、突触可塑性以及细胞凋亡和自噬过程,这表明circRNAs可能是替代性生物标志物和治疗靶点。我们的综述总结了circRNAs在AD进展和发展中的功能,为circRNAs在AD诊断和治疗中的应用前景提供了见解。